Dexrazoxane Intravenous and Indacaterol and glycopyrrolate Inhalation
Determining the interaction of Dexrazoxane Intravenous and Indacaterol and glycopyrrolate Inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Indacaterol inhalation
- Dexrazoxane Intravenous-Indacaterol Maleate
- Dexrazoxane Intravenous-Indapamide
- Dexrazoxane Intravenous-Inderal
- Dexrazoxane Intravenous-Inderal Intravenous
- Dexrazoxane Intravenous-Inderal LA
- Indacaterol and glycopyrrolate Inhalation-Dextenza Insert
- Indacaterol and glycopyrrolate Inhalation-Dextenza intraocular
- Indacaterol and glycopyrrolate Inhalation-Dextran 40
- Indacaterol and glycopyrrolate Inhalation-Dextran 70 6% in 5% Dextrose high molecular weight
- Indacaterol and glycopyrrolate Inhalation-Dextran 75
- Indacaterol and glycopyrrolate Inhalation-Dextran high molecular weight